Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2020 December;61(6) > The Journal of Cardiovascular Surgery 2020 December;61(6):708-12

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  EMERGENT TEVAR 

The Journal of Cardiovascular Surgery 2020 December;61(6):708-12

DOI: 10.23736/S0021-9509.20.11571-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Important issues regarding planning and sizing for emergent TEVAR

Martin TERAA 1 , Constantijn E. HAZENBERG 1, Ignas B. HOUBEN 1, Santi TRIMARCHI 2, 3, Joost A. van HERWAARDEN 1

1 Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, the Netherlands; 2 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 3 Department of Clinical and Community Sciences, University of Milan, Milan, Italy



In the past decades, treatment of acute thoracic aortic syndrome underwent drastic changes with a central role for thoracic endovascular aortic repair (TEVAR). One of the essential factors in the success of TEVAR is accurate sizing of the endograft, as both under- and oversizing can lead to suboptimal results and disastrous complications. The aim of this review was to give an overview of issues regarding endograft sizing in emergent TEVAR. Sizing of the endograft can be complicated by specific factors related to the underlying disease. For instance, different types of the acute thoracic aortic syndrome, i.e. blunt thoracic injury, thoracic aortic aneurysm or dissection with concomitant rupture are associated with hemorrhagic shock and the need for resuscitation, which leads to profound changes in diameter of the thoracic aorta. These diameter changes should be taken into account during endograft sizing. Measuring the thoracic aorta based on the admission CTA can lead to inaccurate sizing, even if proper centerline-based measurements are performed. The use of real-time imaging, in particular intravascular ultrasound (IVUS), has been shown to provide more accurate endograft sizing in acute thoracic aortic syndromes, especially if associated with hypovolemia. Future research should provide additional data on the exact role of different intra-operative imaging modalities (e.g. IVUS, transesophageal echocardiography [TEE], three dimensional CTA) on endograft sizing and long-term outcomes to ultimately improve patient outcome.


KEY WORDS: Aorta; Aortic aneurysm; Wounds and injuries

top of page